Figure S24. (A) Immune gene expression program signature scored from bulk RNA-seq profiles across all samples separated by timepoint. (B) Immunogenic cell death signatures scored from bulk RNA-seq profiles split by fast and slow progressing patients and by timepoint.
No takes yet. Share an insight, caveat, or question.
An et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: